Frankfurt - Delayed Quote EUR

BioHarvest Sciences Inc. (8MV0.F)

5.70
+0.32
+(5.95%)
At close: May 9 at 8:08:39 AM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
25,188
25,188
12,672
5,498
2,102
Cost of Revenue
11,246
11,246
7,039
4,279
1,432
Gross Profit
13,942
13,942
5,633
1,219
670
Operating Expense
20,931
20,931
15,599
11,831
9,161
Operating Income
-6,989
-6,989
-9,966
-10,612
-8,491
Net Non Operating Interest Income Expense
-5,433
-5,433
-2,098
-1,485
-852
Other Income Expense
-483
-483
-500
861
-484
Pretax Income
-12,905
-12,905
-12,564
-11,236
-9,827
Tax Provision
8
8
0
--
--
Net Income Common Stockholders
-12,913
-12,913
-12,564
-11,236
-9,827
Diluted NI Available to Com Stockholders
-12,913
-12,913
-12,564
-11,236
-9,827
Basic EPS
-1.28
-0.80
-0.93
-0.70
-0.70
Diluted EPS
-1.28
-0.80
-0.93
-0.70
-0.70
Basic Average Shares
15,370.40
16,193.79
13,533.16
13,053.64
12,447.70
Diluted Average Shares
15,370.40
16,193.79
13,533.16
13,053.64
12,447.70
Total Operating Income as Reported
-6,989
-6,989
-9,966
-10,612
-8,491
Rent Expense Supplemental
27
27
26
39
14
Total Expenses
32,177
32,177
22,638
16,110
10,593
Net Income from Continuing & Discontinued Operation
-12,913
-12,913
-12,564
-11,236
-9,827
Normalized Income
-12,531.43
-12,531.43
-12,064
-12,097
-9,343
Interest Income
--
--
--
--
0
Interest Expense
4,738
4,738
1,962
1,399
805
Net Interest Income
-5,433
-5,433
-2,098
-1,485
-852
EBIT
-8,167
-8,167
-10,602
-9,837
-9,022
EBITDA
-6,916
-6,916
-9,762
-9,125
-8,633
Reconciled Cost of Revenue
10,394
10,394
6,353
3,738
1,316
Reconciled Depreciation
1,251
1,251
840
712
389
Net Income from Continuing Operation Net Minority Interest
-12,913
-12,913
-12,564
-11,236
-9,827
Total Unusual Items Excluding Goodwill
-483
-483
-500
861
-484
Total Unusual Items
-483
-483
-500
861
-484
Normalized EBITDA
-6,433
-6,433
-9,262
-9,986
-8,149
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-101.43
-101.43
0
0
0
12/31/2021 - 12/9/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade